Glucotrack hits trial success for direct blood measuring CGM
Glucotrack says it has designed its subclavian vein-installed CBGM for three years of continuous use.
Medical Devices
Tivic hits enrolment target for vagus nerve stimulation trial
Intelligent gears up for FDA approval of fingerprint drug detection device
Sinaptica’s neuromodulation device aces Phase II Alzheimer’s trial
Nexalin trials Halo neurostimulation device in traumatic brain injury
Mixed results for Nexalin’s transcranial alternating current stimulation trial
Adaptive deep brain stimulation trial results poised to “transform” Parkinson’s disease
SetPoint’s neuromodulation implant wins IDE for multiple sclerosis study
